← All organizations

Neurovance, Inc.

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 1, 2015

Acquired by Otsuka on Mar 2, 2017

Timeline

2000s

Jan 1, 2009
Neurovance, Inc.— Founded

2010s

Mar 2, 2017
Otsuka— Acquired By

Drugs by trial phase (3 distinct, 5 trials)

Phase 2 (1 own, 0 via acquisition)

centanafadine

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (5)

NCT02827513Lead sponsorPhase 1Dec 1, 2015
NCT02547428Lead sponsorPhase 2Aug 1, 2015
NCT02144415Lead sponsorPhase 1May 1, 2014
NCT01939353Lead sponsorPhase 2Sep 1, 2013
NCT01744808Lead sponsorPhase 1Feb 1, 2013

Details

Founded: Cambridge, MA, US Jan 1, 2009
Last known activity: Dec 1, 2015